132 related articles for article (PubMed ID: 34990694)
1. Therapeutic Potential of Nitric Oxide‒Releasing Selective Estrogen Receptor Modulators in Malignant Melanoma.
Bechmann N; Calsina B; Richter S; Pietzsch J
J Invest Dermatol; 2022 Aug; 142(8):2217-2227. PubMed ID: 34990694
[TBL] [Abstract][Full Text] [Related]
2. Nitric Oxide-Releasing Selective Estrogen Receptor Modulators: A Bifunctional Approach to Improve the Therapeutic Index.
Bechmann N; Kniess T; Pietzsch J
J Med Chem; 2019 Jul; 62(14):6525-6539. PubMed ID: 31099568
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
[TBL] [Abstract][Full Text] [Related]
4. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
5. Effect of estrogen in malignant melanoma.
Bhari N; Schwaertz RA; Apalla Z; Salerni G; Akay BN; Patil A; Grabbe S; Goldust M
J Cosmet Dermatol; 2022 May; 21(5):1905-1912. PubMed ID: 34416066
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ERα but not ERβ or GPR30 signalling.
Rzemieniec J; Litwa E; Wnuk A; Lason W; Gołas A; Krzeptowski W; Kajta M
J Steroid Biochem Mol Biol; 2015 Feb; 146():26-37. PubMed ID: 24846829
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo molecular imaging of estrogen receptor α and β homo- and heterodimerization: exploration of new modes of receptor regulation.
Paulmurugan R; Tamrazi A; Massoud TF; Katzenellenbogen JA; Gambhir SS
Mol Endocrinol; 2011 Dec; 25(12):2029-40. PubMed ID: 22052998
[TBL] [Abstract][Full Text] [Related]
8. Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells.
Sotoca AM; van den Berg H; Vervoort J; van der Saag P; Ström A; Gustafsson JA; Rietjens I; Murk AJ
Toxicol Sci; 2008 Oct; 105(2):303-11. PubMed ID: 18644836
[TBL] [Abstract][Full Text] [Related]
9. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms mediating the neuroprotective role of the selective estrogen receptor modulator, bazedoxifene, in acute ischemic stroke: A comparative study with 17β-estradiol.
Jover-Mengual T; Castelló-Ruiz M; Burguete MC; Jorques M; López-Morales MA; Aliena-Valero A; Jurado-Rodríguez A; Pérez S; Centeno JM; Miranda FJ; Alborch E; Torregrosa G; Salom JB
J Steroid Biochem Mol Biol; 2017 Jul; 171():296-304. PubMed ID: 28479229
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation and modulation of interaction of estrogen receptors with coregulators induced by ERα and ERβ agonists.
Evers NM; van den Berg JH; Wang S; Melchers D; Houtman R; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
J Steroid Biochem Mol Biol; 2014 Sep; 143():376-85. PubMed ID: 24923734
[TBL] [Abstract][Full Text] [Related]
12. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
[TBL] [Abstract][Full Text] [Related]
13. Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy.
Ruddy SC; Lau R; Cabrita MA; McGregor C; McKay BC; Murphy LC; Wright JS; Durst T; Pratt MA
Mol Cancer Ther; 2014 Jul; 13(7):1882-93. PubMed ID: 24785256
[TBL] [Abstract][Full Text] [Related]
14. Selective estrogen receptor-beta (SERM-beta) compounds modulate raphe nuclei tryptophan hydroxylase-1 (TPH-1) mRNA expression and cause antidepressant-like effects in the forced swim test.
Clark JA; Alves S; Gundlah C; Rocha B; Birzin ET; Cai SJ; Flick R; Hayes E; Ho K; Warrier S; Pai L; Yudkovitz J; Fleischer R; Colwell L; Li S; Wilkinson H; Schaeffer J; Wilkening R; Mattingly E; Hammond M; Rohrer SP
Neuropharmacology; 2012 Nov; 63(6):1051-63. PubMed ID: 22796107
[TBL] [Abstract][Full Text] [Related]
15. Acteoside and martynoside exhibit estrogenic/antiestrogenic properties.
Papoutsi Z; Kassi E; Mitakou S; Aligiannis N; Tsiapara A; Chrousos GP; Moutsatsou P
J Steroid Biochem Mol Biol; 2006 Jan; 98(1):63-71. PubMed ID: 16198557
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells.
Smollich M; Götte M; Fischgräbe J; Radke I; Kiesel L; Wülfing P
Anticancer Res; 2009 Jun; 29(6):2167-71. PubMed ID: 19528477
[TBL] [Abstract][Full Text] [Related]
17. Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.
Jonsson P; Katchy A; Williams C
Endocr Relat Cancer; 2014 Apr; 21(2):143-60. PubMed ID: 24192230
[TBL] [Abstract][Full Text] [Related]
18. Selectively targeting estrogen receptors for cancer treatment.
Shanle EK; Xu W
Adv Drug Deliv Rev; 2010 Oct; 62(13):1265-76. PubMed ID: 20708050
[TBL] [Abstract][Full Text] [Related]
19. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
[TBL] [Abstract][Full Text] [Related]
20. Estrogens, estrogen receptors and melanoma.
de Giorgi V; Gori A; Grazzini M; Rossari S; Scarfì F; Corciova S; Verdelli A; Lotti T; Massi D
Expert Rev Anticancer Ther; 2011 May; 11(5):739-47. PubMed ID: 21554049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
